Clinical Trial Update: A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates adding enzalutamide to salvage radiotherapy in men with recurrent prostate cancer after prostatectomy, to see if the combination im…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Xtandi (enzalutamide)

Snippet

Sponsor: RTOG Foundation, Inc. | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-10-16